A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML
Guangzhou Lupeng Pharmaceutical Company LTD.
Guangzhou Lupeng Pharmaceutical Company LTD.
Ascentage Pharma Group Inc.
University of Birmingham
Biocity Biopharmaceutics Co., Ltd.
Fred Hutchinson Cancer Center
Hutchmed
Centre Hospitalier Universitaire de Nice
Vastra Gotaland Region
Groupe Francophone des Myelodysplasies
Arbeitsgemeinschaft medikamentoese Tumortherapie
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
King's College London
National Cancer Institute (NCI)
National Cancer Institute (NCI)